Clinical Characteristics Most Strictly Related to OS, RFS, and FFS After MOPPEBVCAD (+RT)
| Clinical Covariates . | OS (P) . | RFS (P) . | FFS (P) . | ||
|---|---|---|---|---|---|
| Age | .0005 | — | — | .0104 | — |
| Histology | .0671 | .0862 | .0012 | .0016 | .0019 |
| Karnofsky index | >.1 | .0633 | — | >.1 | .0257 |
| Bone marrow involvement | >.1 | .0021 | >.1 | >.1 | >.1 |
| DI of CT cycles 1-3 | >.1 | >.1 | — | — | — |
| SLNG prognostic index | >.1 | >.1 | — | >.1 | >.1 |
| IDHD 5-yr OS estimate | >.1 | >.1 | >.1 | >.1 | >.1 |
| Clinical Covariates . | OS (P) . | RFS (P) . | FFS (P) . | ||
|---|---|---|---|---|---|
| Age | .0005 | — | — | .0104 | — |
| Histology | .0671 | .0862 | .0012 | .0016 | .0019 |
| Karnofsky index | >.1 | .0633 | — | >.1 | .0257 |
| Bone marrow involvement | >.1 | .0021 | >.1 | >.1 | >.1 |
| DI of CT cycles 1-3 | >.1 | >.1 | — | — | — |
| SLNG prognostic index | >.1 | >.1 | — | >.1 | >.1 |
| IDHD 5-yr OS estimate | >.1 | >.1 | >.1 | >.1 | >.1 |
Results of multivariate analysis with a proportional hazards regression model. Covariates entering the study were the best ones emerging from univariate analysis (bold and italic fonts indicate statistical probability of the null hypothesis <.05 or ranging from .10 to .05, respectively).